- Home
- PMAX vs EVOK Comparison
PMAX vs EVOK Comparison
Compare PMAX & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMAX
- EVOK
- Stock Information
- Founded
- PMAX 2019
- EVOK 2007
- Country
- PMAX Hong Kong
- EVOK United States
- Employees
- PMAX N/A
- EVOK N/A
- Industry
- PMAX
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- PMAX
- EVOK Health Care
- Exchange
- PMAX Nasdaq
- EVOK Nasdaq
- Market Cap
- PMAX 6.0M
- EVOK 5.4M
- IPO Year
- PMAX 2024
- EVOK 2013
- Fundamental
- Price
- PMAX $2.87
- EVOK $4.80
- Analyst Decision
- PMAX
- EVOK
- Analyst Count
- PMAX 0
- EVOK 0
- Target Price
- PMAX N/A
- EVOK N/A
- AVG Volume (30 Days)
- PMAX 90.1K
- EVOK 30.9K
- Earning Date
- PMAX 09-23-2025
- EVOK 11-06-2025
- Dividend Yield
- PMAX N/A
- EVOK N/A
- EPS Growth
- PMAX N/A
- EVOK N/A
- EPS
- PMAX N/A
- EVOK N/A
- Revenue
- PMAX $4,799,100.00
- EVOK $12,794,859.00
- Revenue This Year
- PMAX N/A
- EVOK $57.38
- Revenue Next Year
- PMAX N/A
- EVOK $59.57
- P/E Ratio
- PMAX N/A
- EVOK N/A
- Revenue Growth
- PMAX N/A
- EVOK 70.02
- 52 Week Low
- PMAX $1.87
- EVOK $1.94
- 52 Week High
- PMAX $31.92
- EVOK $12.32
- Technical
- Relative Strength Index (RSI)
- PMAX 91.41
- EVOK 43.60
- Support Level
- PMAX $0.26
- EVOK $4.23
- Resistance Level
- PMAX $0.29
- EVOK $4.94
- Average True Range (ATR)
- PMAX 0.15
- EVOK 0.30
- MACD
- PMAX 0.26
- EVOK -0.06
- Stochastic Oscillator
- PMAX 84.69
- EVOK 46.36
About PMAX Powell Max Limited Class A Ordinary Shares
Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.